| 000 | 01319 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516105249.0 | ||
| 264 | 0 | _c20130109 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1744-8344 | ||
| 024 | 7 |
_a10.1586/erc.12.56 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacobson, Terry A | |
| 245 | 0 | 0 |
_aA new pure ω-3 eicosapentaenoic acid ethyl ester (AMR101) for the management of hypertriglyceridemia: the MARINE trial. _h[electronic resource] |
| 260 |
_bExpert review of cardiovascular therapy _cJun 2012 |
||
| 300 |
_a687-95 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEicosapentaenoic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertriglyceridemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 773 | 0 |
_tExpert review of cardiovascular therapy _gvol. 10 _gno. 6 _gp. 687-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/erc.12.56 _zAvailable from publisher's website |
| 999 |
_c22026460 _d22026460 |
||